Bullous pemphigoid induced by penicillamine in a patient with Wilson disease

American Journal of Clinical Dermatology

Volumn 10, Issue 1, 2009, Pages 36-38

  Popadic, Svetlana ^a,b   Skiljevic, Dusan ^a,b   Medenica, Ljiljana ^a,b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Bullous pemphigoid; Penicillamine, adverse reactions; Wilson's disease

Indexed keywords

BETAMETHASONE; CLOBETASOL; PENICILLAMINE; ZINC SULFATE;

ADULT; ARTICLE; BULLOUS PEMPHIGOID; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; LABORATORY TEST; LIMB; MALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; SKIN BIOPSY; TRUNK; WILSON DISEASE;

CHELATING AGENTS; DIAGNOSIS, DIFFERENTIAL; HEPATOLENTICULAR DEGENERATION; HUMANS; MALE; MIDDLE AGED; PEMPHIGOID, BULLOUS; PENICILLAMINE;

EID: 58849142480     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/0128071-200910010-00006     Document Type: Article

References (28)

1. Das SK, Ray K. Wilson's disease: an update. Nat Clin Pract Neurol 2006 Sep; 2 (9): 482-93
2. Munro R, Capell HA. Penicillamine. Br J Rheumatol 1997 Jan; 36 (1): 104-9
3. Lee JJ, Downham 2nd TF. Furosemide-induced bullous pemphigoid: case report and review of literature. J Drugs Dermatol 2006 Jun; 5 (6): 562-4
4. Femiano F. Mucocutaneous bullous pemphigoid induced by valsartan: a clinical case. Minerva Stomatol 2003 Apr; 52 (4): 187-90
5. Millard TP, Smith HR, Black MM, et al. Bullous pemphigoid developing during systemic therapy with chloroquine. Clin Exp Dermatol 1999 Jul; 24 (4): 263-5
6. Mallet L, Cooper JW, Thomas J. Bullous pemphigoid associated with captopril. DICP 1989 Jan; 23 (1): 63
7. Hodak E, Ben-Shetrit A, Ingber A, et al. Bullous pemphigoid: an adverse effect of ampicillin. Clin Exp Dermatol 1990 Jan; 15 (1): 50-2
8. Yamaguchi R, Oryu F, Hidano A. A case of bullous pemphigoid induced by tiobutarit (D-penicillamine analogue). J Dermatol 1989 Aug; 16 (4): 308-11
9. Pegum JS, Pembroke AC. Benign mucous-membrane pemphigoid associated with penicillamine treatment [letter]. BMJ 1977 Jun 4; 1 (6074): 1473
10. Troy JL, Silvers DN, Grossman ME, et al. Penicillamine-associated pemphigus: is it really pemphigus? J Am Acad Dermatol 1981 May; 4 (5): 547-55
11. Velthuis PJ, Hendrikse JC, Nefkens JJ. Combined features of pemphigus and pemphigoid induced by penicillamine. Br J Dermatol 1985 May; 112 (5): 615-9
12. Rasmussen HB, Jepsen LV, Brandrup F. Penicillamine-induced bullous pemphigoid with pemphigus-like antibodies. J Cutan Pathol 1989 Jun; 16 (3): 154-7
13. Weller R, White MI. Penicillamine in the etiology of bullous pemphigoid. Ann Pharmacother 1998 Dec; 32 (12): 1368
14. Weller R, White MI. Bullous pemphigoid and penicillamine. Clin Exp Dermatol 1996 Mar; 21 (2): 121-2
15. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981 Aug; 30 (2): 239-45
16. Medenica-Mojsilovic L, Fenske NA, Espinoza CG. Epidermolysis bullosa acquisita: direct immunofluorescence and ultrastructural studies. Am J Dermatopathol 1987 Aug; 9 (4): 324-33
17. Smolarek C, Stremmel W. Therapy of Wilson disease. Gastroenterol 1999 Apr; 37 (4): 293-300
18. Jan V, Callens A, Machet L, et al. D-penicillamine-induced pemphigus, polymyositis and myasthenia. Ann Dermatol Venereol 1999 Feb; 126 (2): 153-6
19. Ayoub N. Pemphigus and pemphigus-triggering drugs. Ann Dermatol Venereol 2005 Jun-Jul; 132 (6-7 Pt 1): 5
20. Brenner S, Wolf R, Ruocco V. Drug-induced pemphigus: I. A survey. Clin Dermatol 1993 Oct-Dec; 11 (4): 501-5
21. Marti-Huguet T, Quintana M, Cabiro I. Cicatricial pemphigoid associated with D-penicillamine treatment [letter]. Arch Ophthalmol 1989 Aug; 107 (8): 1115
22. Peyri J, Servitje O, Ribera M, et al. Cicatricial pemphigoid in a patient with rheumatoid arthritis treated with D-penicillamine [letter]. J Am Acad Dermatol 1986 Apr; 14 (4): 681
23. Shuttleworth D, Graham-Brown RA, Hutchinson PE, et al. Cicatricial pemphigoid in D-penicillamine treated patients with rheumatoid arthritis: a report of three cases. Clin Exp Dermatol 1985 Jul; 10 (4): 392-7
24. Cetkovska P, Pizinger K, Skalova A. Epidermolysis bullosa acquisita-like reaction associated with penicillamine therapy for sclerodermatous graft-versus-host disease. J Am Acad Dermatol 2003 Dec; 49 (6): 1157-9
25. Langan SM, Smeeth L, Hubbard R, et al. Bullous pemphigoid and pemphigus vulgaris: incidence and mortality in the UK: population based cohort study. BMJ 2008 Jul 9; 337: 160-3
26. Bialy-Golan A, Brenner S. Penicillamine-induced bullous dermatoses. J Am Acad Dermatol 1996; 35 (5): 732-42
27. Benveniste M, Crouzet J, Homberg JC, et al. Pemphigus induced by D-penicillamine in rheumatoid arthritis: study of 5 cases and systematic study of anti-intercellular substance antibodies of the skin in the course of treatment. Nouv Presse Med 1975 Dec; 4 (44): 3125-8
28. Rawlins MD. Pharmacovigilance: paradise lost, regained or postponed? J R Coll Physicians Lond 1995 Jan-Feb; 29 (1): 41-9